Roan Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Roan Capital Partners's LLY Position: Q3 2026 in Review
Roan Capital Partners increased its Eli Lilly (LLY) stake by 20% in Q3 2026, buying an estimated $46K and bringing the position to 235 shares worth $272K. The position accounts for 0.2% of the portfolio, ranked #65.
Roan Capital Partners first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. 4,631 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Roan Capital Partners held 235 shares of Eli Lilly worth $272K as of Q3 2026.
- Roan Capital Partners bought 39 Eli Lilly shares in Q3 2026, an estimated $46K.
- Eli Lilly made up 0.2% of Roan Capital Partners's portfolio in Q3 2026, its #65 holding.
- Roan Capital Partners first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
- 4,631 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Roan Capital Partners's 13F filing for Q3 2026, filed 9 Oct 2026.